ESC: Eli Lilly, Boehringer’s Jardiance slices CV events by 25% in Farxiga-matching heart failure trial

ESC: Eli Lilly, Boehringer’s Jardiance slices CV events by 25% in Farxiga-matching heart failure trial
kblankenship
Fri, 08/28/2020 – 17:20